Priya Mande

Priya Mande is Chief Executive Officer of RNAvate, focused on the development of novel circular RNA therapeutics out of the Molecular Research Laboratories (MRC), in Cambridge UK.

Priya was previously a founding member of PsiOxus Therapeutics, a member of the UK Government Covid-19 Vaccine Taskforce and a Vaccine Project Leader at Pfizer.  Priya has a wealth of experience in transforming academic spin outs to award winning companies through raising capital, establishing & leading high performing teams, deal making and creating shareholder & patient centric value.